SCHEMBL7776556

SCHEMBL7776556

Cc1nc2cnccc2n1-c1ccc(Cn2c(=O)sc3cc(C(F)(F)F)ccc32)cc1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7774890 0.93
SCHEMBL7774503 0.88 BRD4 (0.39)
SCHEMBL7776564 0.88
SCHEMBL7774882 0.87 BRD4 (0.45)
SCHEMBL7774780 0.87 MEN1 (0.44)
SCHEMBL7770171 0.85 BRD4 (0.44)
SCHEMBL7776569 0.85 SMN1; SMN2 (0.42)
SCHEMBL7776415 0.85 POLB (0.47)
SCHEMBL6705396 0.84 L3MBTL1 (0.51)
SCHEMBL7770183 0.84

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1125936-A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases Pfizer Products Inc. (US) 2001-08-22 EP claimed
US-6242461-B1 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases PFIZER INC. 2001-06-05 US claimed
EP-1125936-A2 Aryl substituted azabenzimidazoles and their use in the treatment of HIV and AIDS related diseases Pfizer Products Inc. (US) 2001-08-22 EP disclosed
US-6242461-B1 Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases PFIZER INC. 2001-06-05 US disclosed